Piper Sandler Raises Price Target on Kimberly‑Clark Amid Mixed Q2 Results

Kimberly‑Clark (NYSE: KMB) garnered renewed analyst attention in the past week after Piper Sandler raised its price target to $121 from $115, reflecting confidence in the company’s margin resilience and long-term strategy despite ongoing headwinds.

Analyst Update Highlights

On Tuesday, Piper Sandler increased its price target on Kimberly‑Clark shares to $121—a boost from the previous $115 level—indicating a more positive view of the company’s performance and prospects amid near-term challenges.

This update comes after the second quarter earnings report released in early August showed adjusted earnings per share attributable to Kimberly‑Clark of $2.12, representing a 10.4% year-over-year increase and topping the consensus estimate of $2.01, while total net sales of $4.19 billion fell slightly short of the $4.22 billion forecast.

Q2 Financials and Guidance Overview

Kimberly‑Clark’s Q2 results revealed a mixed picture: strong profitability paired with soft organic growth. Core adjusted EPS growth was driven by productivity gains, tariff refunds and equity income, while organic sales were dragged down by a China social media crisis and continued inventory pressures in North America.

Management revised its full‑year guidance to reflect these pressures. Adjusted operating profit is now expected to grow in the mid‑single digits (constant currency), adjusted EPS from continuing operations is projected to grow in the high‑single digits, and adjusted EPS attributable to Kimberly‑Clark is forecasted to see a low‑single‑digit decline. Organic sales growth is expected to run roughly 100 basis points below category growth, primarily due to China market disruption.

Stock Performance Context

Kimberly‑Clark’s stock closed at the verified price of $97.59 as of October 9, 2026, reflecting a modest gain of 0.15% that day. Piper Sandler’s new target implies a notable upside from the current levels, underscoring analyst expectations that operational strength should eventually offset near‑term volatility.

What Investors Should Watch

As the company prepares for its Q3 earnings report—expected around October 29, 2026—investors will closely monitor whether productivity and margin improvements continue to offset continued organic softness. Key drivers to track include China market recovery, North American inventory stabilization, and progress on the Kenvue acquisition.

Given the updated analyst outlook and current performance dynamics, the stock appears to be pricing in a gradual turnaround anchored by underlying efficiencies and brand execution.

Verified share price: $97.59 (as of October 9, 2026, with a 0.15% daily gain).
Analyst action: Piper Sandler raised price target to $121.
Earnings recap: Q2 adjusted EPS at $2.12 beats $2.01 estimate; organic sales weak; guidance trimmed with low‑single‑digit decline in EPS attributable.